FDA.reportPublic FDA data

repaglinide 0.5 MG Oral Tablet

RxCUI
200257
RxNorm name
repaglinide 0.5 MG Oral Tablet
Display name
repaglinide 0.5 MG Oral Tablet
Full name
repaglinide 0.5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RepaglinideREPAGLINIDENorthStar RxLLC7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b6652025-09-15Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDEChartwell RX, LLCcb995e92-295e-4638-a064-978211f5afe12025-05-02Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDEBryant Ranch Prepack9f2006d9-e0c0-4cc4-b2c9-84b7d9f771732025-01-23Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDEBryant Ranch Prepack3b150917-e2fd-4366-af83-ebc1d7297ca92025-01-16Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDEAurobindo Pharma Limited68064989-47ea-4ed5-a20e-43c4ef6ec2712024-05-14Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDERising Pharma Holdings, Inc.d7673e22-0dbb-4395-ad60-943d249203a12024-05-14Warnings, Adverse reactionsExact identifier
rxcui: 200257
RepaglinideREPAGLINIDEMacleods Pharmaceuticals Limited7a93246c-9323-40c4-b590-a40dcb133c8c2023-04-04Warnings, Adverse reactionsExact identifier
rxcui: 200257

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68064989-47ea-4ed5-a20e-43c4ef6ec271repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720240514
d7673e22-0dbb-4395-ad60-943d249203a1repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720240514
813f781f-7db8-49ed-b4ed-a829c37eddb7repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]25These highlights do not include all the information needed to use PRANDIN safely and effectively. See full prescribing information for PRANDIN. Initial U.S. Approval: 199720171228
7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250915
cb995e92-295e-4638-a064-978211f5afe1repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]21REPAGLINIDE TABLETS These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250502
9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250123
3b150917-e2fd-4366-af83-ebc1d7297ca9repaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250116
7a93246c-9323-40c4-b590-a40dcb133c8crepaglinide 0.5 MG Oral Tablet [PSN] · repaglinide 0.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720230404